Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E27.38 EPS (ttm)1.42 Insider Own0.20% Shs Outstand1.53B Perf Week-11.75%
Market Cap59.55B Forward P/E15.69 EPS next Y2.48 Insider Trans-13.49% Shs Float1.47B Perf Month-6.44%
Income2.13B PEG2.88 EPS next Q0.53 Inst Own70.80% Short Float0.86% Perf Quarter3.40%
Sales20.39B P/S2.92 EPS this Y53.50% Inst Trans-0.02% Short Ratio1.73 Perf Half Y-12.01%
Book/sh14.40 P/B2.70 EPS next Y12.48% ROA- Target Price47.20 Perf Year-14.25%
Cash/sh- P/C- EPS next 5Y9.49% ROE- 52W Range35.78 - 50.81 Perf YTD-12.30%
Dividend1.04 P/FCF- EPS past 5Y-10.30% ROI7.70% 52W High-23.44% Beta0.99
Dividend %2.67% Quick Ratio- Sales past 5Y-10.30% Gross Margin56.90% 52W Low8.72% ATR0.91
Employees74000 Current Ratio- Sales Q/Q-0.20% Oper. Margin13.60% RSI (14)27.08 Volatility2.33% 1.74%
OptionableYes Debt/Eq- EPS Q/Q-89.20% Profit Margin12.00% Rel Volume4.19 Prev Close40.42
ShortableYes LT Debt/Eq- EarningsApr 20 BMO Payout60.90% Avg Volume7.31M Price38.90
Recom2.00 SMA20-9.53% SMA50-5.06% SMA200-9.25% Volume30,645,058 Change-3.76%
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jul-18-13Reiterated Barclays Equal Weight $35 → $37
Apr-30-16 12:01AM  [$$] Charting the Market at
Apr-29-16 08:33PM  [$$] Business Watch at The Wall Street Journal
05:22PM  Worst may be over for embattled pharma Yahoo Finance Contributors
04:14PM  $45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There Benzinga
03:45PM  Abbott Labs (ABT) Stock Plunges, Needham Downgrades on St. Jude Acquisition Concerns at TheStreet
02:14PM  Analysts Split On Abbott Lab's Purchase Of St. Jude at
01:54PM  Alere (ALR) Stock Plummets, Rejects Abbott's Request to End Merger at TheStreet
12:32PM  Pharma stocks to bet on CNBC
12:10PM  Valeant May Be Tip of Accounting Iceberg at Bloomberg
11:12AM  Correction: Abbott-St Jude Acquisition story AP
09:42AM  Faber Report: Abbott Labs CEO says Alere 'working through... CNBC
09:20AM  Abbott to Buy St. Jude Medical for $25 Billion at Investopedia
08:10AM  Abbott Laboratories breached its 50 day moving average in a Bearish Manner : ABT-US : April 29, 2016 at Capital Cube
08:01AM  The C-Suite Speaks: Looking for a Curveball Yahoo Finance Contributors
12:38AM  [$$] Abbott Agrees to Buy St. Jude in $25 Billion Deal at The Wall Street Journal
Apr-28-16 07:13PM  [$$] Abbott Agrees to Buy St. Jude in $25 Billion Deal at The Wall Street Journal -7.78%
07:02PM  Cramer: Worst May Be Over for Embattled Pharma at TheStreet
05:56PM  Why Textura, St. Jude Medical, and Cliffs Natural Resources Jumped Today at Motley Fool
05:01PM  US stocks skid as Apple pulls tech companies lower AP
04:52PM  [$$] Xilinx slides on downbeat sales outlook at Financial Times
04:43PM  US STOCKS-Wall St sinks on BOJ fears, Icahn comments Reuters
04:41PM  LPC: Abbotts $17.2 billion loan backing St. Jude acquisition set to boost M&A volume Reuters
04:40PM  Stocks End Sharply Lower; Amazon Surges Late On Earnings at Investor's Business Daily
04:37PM  Abbott deal for St. Jude spurs company split talk Reuters
04:31PM  Abbott Laboratories to buy St. Jude Medical for $25 billion at USA TODAY
04:26PM  WALL STREET PAYDAY: Banks could make up to $340 million from Takeover Thursday Business Insider
04:23PM  Medical M&A Rules The Day As Abbott, AbbVie Make Buys, Sanofi Bids at Investor's Business Daily
04:06PM  Apple Wipes Out Any Nasdaq Gains in Another Selloff at TheStreet
03:41PM  US STOCKS-Wall St flounders on BOJ fears as Facebook, M&A boosts wane Reuters
03:20PM  Abbott Labs buying St. Jude Medical in $25B deal at American City Business Journals
03:02PM  Abbott Laboratories -- Moody's: Abbott's ratings remain on review for downgrade after announced St. Jude Medical deal at Moody's
03:01PM  Takeover Thursday CNBC
02:08PM  Health Care M&A: It's Back at The Wall Street Journal
02:06PM  Morningstar Analyst: Abbott Laboratories' Acquisition Of St. Jude Medical 'Makes A Lot Of Strategic Sense' Benzinga
02:00PM  More Squawk From Jim Cramer: 'If Abbott Comes Back Down, Just Buy It' at TheStreet
01:38PM  $31 Billion St. Jude Purchase Will Take a While for Abbott to Digest at TheStreet
01:30PM  $40 Billion Takeover Has Big Pharma Giddy at TheStreet
01:05PM  LPC: Abbott's US$17.2bn loan backing St. Jude acq. set to boost M&A volume Reuters
01:01PM  Big health care deals CNBC
12:57PM  US STOCKS-Wall St recovers as Facebook, M&A cushion BOJ shock Reuters
12:56PM  Abbott to buy St. Jude for $25 billion to boost heart devices Reuters
12:36PM  Thursday links: costs vs. discipline Yahoo Finance Contributors
12:05PM  Abbott's Dream Deal Doesn't Come Cheap at Bloomberg
12:00PM  Why St. Jude Medical, Inc. Acquired a Higher Price Today at Motley Fool
12:00PM  Stocks Pare Losses; GDP, BoJ Inaction Eyed Morningstar
11:57AM  Stocks Remain Mixed as Facebook Boosts Nasdaq at TheStreet
11:28AM  US STOCKS-Wall St gets a lift from Facebook, corporate M&A Reuters
11:20AM  Abbott Investors Aren't Happy With St. Jude Deal at The Wall Street Journal
11:06AM  Abbott Boosts Cardio Device Business With $25 Billion St. Jude Buy at Investor's Business Daily
10:57AM  Nasdaq Leads Stocks Higher After Facebook Earnings Win at TheStreet
10:57AM  Jim Cramer: I'm a Huge Backer of Abbott Labs CEO Miles White at TheStreet
10:39AM  Abbott 'bulks up' with St. Jude CNBC
10:10AM  Abbott-St. Jude Combination: Why It Makes Sense Bloomberg
10:10AM  Abbott-St. Jude Combination: Why It Makes Sense at Bloomberg
10:06AM  What to Expect from Boston Scientifics 1Q16 Earnings Market Realist
10:05AM  Heres Why Traders Are Buzzing About These Five Hot Stocks at Insider Monkey
10:04AM  [$$] Abbott to buy St Jude in $25bn deal at Financial Times
09:49AM  'Just right' timing to buy St. Jude: Abbott CEO CNBC
09:47AM  Product makes us competitive, not tax: Abbott CEO CNBC
09:45AM  Abbott Labs' 'super transaction' after buying St. Jude CNBC
09:40AM  Stocks to Watch: Facebook, Abbott Labs, St. Jude at The Wall Street Journal
09:24AM  Facebook surges to new high, Priceline CEO steps down Yahoo Finance
09:05AM  U.S. stock futures tumble after weak U.S. GDP, BOJ surprise at MarketWatch
09:01AM  Abbott Labs to buy St. Jude Medical CNBC
08:30AM  St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of St. Jude Medical, Inc.; Are Shareholders Getting a Fair Price? PR Newswire
08:15AM  Early movers: STJ, F, FB, DNKN, AET, RTN, BZH, CAB, PYPL & more at CNBC
08:10AM  GDP disappoints, BOJ surprise Yahoo Finance
08:09AM  Abbott to spend $19.3 billion to buy device maker St. Jude Medical at Los Angeles Times
08:06AM  Abbott to buy St. Jude for $25 bln to boost heart devices business Reuters
07:54AM  Abbott to Purchase St. Jude Medical in $25 Billion Deal Bloomberg
07:53AM  Abbott to Purchase St. Jude Medical in $25 Billion Deal at Bloomberg
07:38AM  Wall Street set to slide after BOJ shocks markets at CNBC
07:38AM  St. Jude Soars 30% After Abbott Announces $25 Billion Acquisition Benzinga
07:18AM  Abbott Labs to buy St. Jude CNBC
07:08AM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement EDGAR Online
07:04AM  Abbott Labs agrees to buy St. Jude Medical in deal valued at $25 billion at MarketWatch
07:00AM  Abbott Labs is buying St. Jude Medical for $25 billion Business Insider
06:56AM  Abbott to acquire St. Jude Medical for $25 bln Reuters
06:55AM  Abbott to buy St. Jude for $85 per share CNBC
06:53AM  Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion at Bloomberg
06:50AM  Abbott to Acquire St. Jude Medical PR Newswire
Apr-26-16 09:06PM  What Do Analysts Recommend for Abbott after 1Q16 Results? Market Realist
06:07PM  Abbotts Nutrition Segment Reported Strong Sales Growth in 1Q16 Market Realist
09:30AM  What's the Secret to Living a Full Life? A New Global Survey Reveals Family Comes First PR Newswire
09:08AM  How Did Abbotts Medical Device Segment Perform in 1Q16? Market Realist
Apr-25-16 08:06PM  What Drove Abbotts Diagnostics Division Revenues? Market Realist
07:01PM  Alere Said to Get Default Notice From Creditors on Filing Delay at Bloomberg
Apr-22-16 04:31PM  Currency Headwinds Hurt ABTs Established Pharmaceutical Segment Market Realist
04:29PM  Abbott Beat 1Q16 Estimates despite Strong Currency Headwinds Market Realist
03:00PM  ETFs with exposure to Abbott Laboratories : April 22, 2016 at Capital Cube
10:33AM  Heres what CEOs said on this weeks earnings calls Yahoo Finance Contributors
Apr-21-16 11:20AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
09:10AM  Top Analyst Upgrades and Downgrades: Abbott Labs, Amex, Apple, Citrix, ConocoPhillips, Kinder Morgan, Qualcomm, ServiceNow, Tesla and More at 24/7 Wall St.
09:00AM  Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity PR Newswire
Apr-20-16 03:47PM  UPDATE 4-Alere shares sink after Abbott CEO fuels speculation deal at risk Reuters
03:28PM  Abbott Labs' Commitment Issues at Bloomberg
03:18PM  What's Behind Alere Inc.'s Sinking Shares Today at Motley Fool
02:57PM  Why Alere lost half a billion dollars in market value today at American City Business Journals
01:53PM  Abbott Laboratories (ABT) Stock Slides Despite Q1 Earnings Beat at TheStreet
12:10PM  Here's Why Alere (ALR) Stock Is Plunging Today at TheStreet
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Mnire's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM
Fussell Stephen RExecutive Vice PresidentAug 18Sale50.4613,096660,854130,601Aug 20 05:18 PM
Fussell Stephen RExecutive Vice PresidentAug 11Option Exercise21.2241,500880,605172,101Aug 13 05:02 PM
Funck Robert EVice President, ControllerJul 29Option Exercise21.2226,000551,70497,448Jul 30 05:51 PM
Blaser Brian JExecutive Vice PresidentJul 28Sale50.9611,300575,904102,194Jul 30 05:52 PM
Pavee Jean-YvesSenior Vice PresidentJun 03Option Exercise25.9810,500272,77536,106Jun 05 06:05 PM
Pavee Jean-YvesSenior Vice PresidentJun 03Sale49.0010,500514,50025,606Jun 05 06:05 PM